Skip to content

Advertisement

  • Tutorial
  • Open Access

Lessons from placebo effects in migraine treatment

The Journal of Headache and Pain20078:360

https://doi.org/10.1007/s10194-007-0360-4

  • Received: 3 November 2006
  • Accepted: 8 January 2007
  • Published:

Abstract

In medical research, the placebo effect is an important methodological tool. Placebo is given to participants in clinical trials, with the intention of mimicking an experimental intervention. The "nocebo" effect, on the other hand, is the phenomenon whereby a patient who believes that a treatment will cause harm actually does experience adverse effects. The placebo effect strongly influences the way the results of clinical trials are interpreted. Placebo responses vary with the choice of study design, the choice of primary outcome measure, the characteristics of the patients and the cultural setting in which the trial is conducted. In migraine trials, the placebo response is high, in terms of both efficacy and side effects. Although medical ethics committees are becoming increasingly resistant to the use of placebo in acute migraine trials, placebo nevertheless remains the pivotal comparator in trials of migraine medications.

Key words

  • Placebo
  • Migraine
  • Triptans
  • NSAIDs
  • Nocebo

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement